InvestorsHub Logo
Followers 105
Posts 16351
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Monday, 10/02/2023 8:01:31 AM

Monday, October 02, 2023 8:01:31 AM

Post# of 202

On October 2, 2023, IceCure Medical Ltd. (the “Company”) issued a press release titled: “Independent Study Validates IceCure’s ProSense Cryoablation is Safe & Effective Outpatient Procedure for Breast Cancer with 96.8% Success Rate,” a copy of which is furnished as Exhibit 99.1 with this Report of Foreign Private Issuer on Form 6-K (the “Report”).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ICCM News